Evidence map›Paper›PMID 38740506›Full record

ArticleBMJ open2024

Paediatric off-label use of drugs in Gansu, China: a multicentre cross-sectional study.

Min Meng, Bin Ge, Wenjuan Lei, Yuqiong Wu, Min Tian, Yali Lu, Tingji Shao, Yan Yang, Xufei Luo, Jiawei Luo and 3 more

Abstract readMulticenter Study
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Min MengChevidence Lab Child & Adolescent Health Department, Children's Hospital of Chongqing Medical University, Chongqing, China.
Bin GeDepartment of Pharmacy, Gansu Provincial Hospital, Lanzhou, China.
Wenjuan LeiDepartment of Pharmacy, Gansu Provincial Hospital, Lanzhou, China.
Yuqiong WuDepartment of Pharmacy, Second Provincial People's Hospital of Gansu, Lanzhou, China.
Min TianDepartment of Pharmacy, Gansu Provincial Hospital, Lanzhou, China.
Yali LuDepartment of Pharmacy, Gansu Provincial Hospital, Lanzhou, China.
Tingji ShaoDepartment of Pharmacy, Gansu Provincial Hospital, Lanzhou, China.
Yan YangDepartment of Pharmacy, Gansu Provincial Hospital, Lanzhou, China.
Xufei LuoEvidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Jiawei LuoWest China Biomedical Big Data Center, West China School of Medicine/West China Hospital of Sichuan University, Chengdu, China.
Yang GaoDepartment of Pharmacy, Gansu Provincial Hospital, Lanzhou, China.
Qiu LiNational Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China chevidence@lzu.edu.cn liqiu809@hospital.cqmu.edu.cn.
Yaolong ChenChevidence Lab Child & Adolescent Health Department, Children's Hospital of Chongqing Medical University, Chongqing, China chevidence@lzu.edu.cn liqiu809@hospital.cqmu.edu.cn.ORCID 0000-0002-9841-5233

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine the current prevalence and cost of paediatric off-label drug prescriptions in Gansu, China, and the potential influencing factors.

designThe prevalence of off-label prescriptions in paediatrics was evaluated according to the National Medical Products Administration drug instructions in the China Pharmaceutical Reference (China Pharmaceutical Reference, MCDEX) database. The evidence of the prescription was determined by existing clinical practice guidelines and the Thomson Grade in the Micromedex 2021 compendium. We used logistic regression to investigate the characteristics that influence paediatric off-label drug use after single-factor regression analysis.

settingA multicentre cross-sectional study of outpatient paediatric prescriptions in 196 secondary and tertiary hospitals in Gansu Province, China, in March and September 2020.

resultsWe retrieved 104 029 paediatric prescriptions, of which 39 480 (38.0%) contained off-label use. The most common diseases treated by off-label drugs were respiratory system diseases (n=15 831, 40.1%). A quarter of off-label prescriptions had adequate evidence basis (n=10 130, 25.6%). Unapproved indications were the most common type of off-label drug use (n=25 891, 65.6%). A total of 1177 different drugs were prescribed off-label, with multienzyme tablets being the most common drug (n=1790, 3.5%). The total cost of the prescribed off-label drugs was ¥106 116/day. Off-label prescriptions were less frequent in tertiary than in secondary hospitals. Topical preparations were more commonly prescribed off-label than other types of drugs. Senior-level clinicians prescribed drugs off-label more often than intermediate and junior clinicians.

conclusionOff-label drug use is widespread in paediatric practice in China. Three-quarters of the prescriptions may potentially include inappropriate medication use, resulting in a daily economic burden of about ¥81 000 in 2020 in Gansu Province with 25 million inhabitants. The management of off-label drug use in paediatrics in China needs improvement.

Indexed as

Off-Label UseAdolescentChildChild, PreschoolChinaCross-Sectional StudiesDrug PrescriptionsFemaleHumansInfantInfant, NewbornMalePractice Patterns, Physicians'ChinaCLINICAL PHARMACOLOGYPAEDIATRICS

Identifiers

PMID38740506
PMCPMC11097813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.